Rubius Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Rubius Therapeutics, Inc.‘s stocks are currently a part of 50 hedge funds’ portfolios, which represents 75.35% of the total amount of its stocks outstanding. This makes up a total of 68.01M shares of Rubius Therapeutics, Inc.. Compared to the previous quarter, the number fell by -13.18% or -10.32M shares fewer. As for the holding position changes, 18% (9) of current hedge fund investors increased the number of shares held, 46% (23) of current holders sold a part of the shares held, and 34% (17) closed the holdings completely. 6 hedge funds are new holders of Rubius Therapeutics, Inc. stock in Q3 2022, it is 12% of total holders.
Hedge funds holding Rubius Therapeutics (Q3 2018 – Q3 2022)
| Q3 2018 | 55 |
|---|---|
| Q4 2018 | 56 |
| Q1 2019 | 65 |
| Q2 2019 | 68 |
| Q3 2019 | 75 |
| Q4 2019 | 76 |
| Q1 2020 | 73 |
| Q2 2020 | 84 |
| Q3 2020 | 84 |
| Q4 2020 | 86 |
| Q1 2021 | 104 |
| Q2 2021 | 107 |
| Q3 2021 | 104 |
| Q4 2021 | 105 |
| Q1 2022 | 111 |
| Q2 2022 | 66 |
| Q3 2022 | 50 |
Hedge funds changes in Rubius Therapeutics positions (Q3 2018 – Q3 2022)
| Q3 2018 | 55 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2018 | 11 | 21 | 13 | 10 | 1 |
| Q1 2019 | 14 | 35 | 4 | 5 | 7 |
| Q2 2019 | 13 | 29 | 14 | 8 | 4 |
| Q3 2019 | 10 | 30 | 14 | 3 | 18 |
| Q4 2019 | 12 | 29 | 22 | 11 | 2 |
| Q1 2020 | 12 | 24 | 22 | 14 | 1 |
| Q2 2020 | 21 | 32 | 18 | 11 | 2 |
| Q3 2020 | 11 | 24 | 32 | 11 | 6 |
| Q4 2020 | 12 | 26 | 32 | 9 | 7 |
| Q1 2021 | 31 | 28 | 34 | 12 | -1 |
| Q2 2021 | 24 | 44 | 23 | 21 | -5 |
| Q3 2021 | 11 | 36 | 33 | 14 | 10 |
| Q4 2021 | 14 | 45 | 27 | 13 | 6 |
| Q1 2022 | 19 | 38 | 32 | 12 | 10 |
| Q2 2022 | 18 | 19 | 23 | 60 | -54 |
| Q3 2022 | 6 | 9 | 23 | 17 | -5 |
Hedge funds changes in Rubius Therapeutics stock options (Q3 2018 – Q3 2022)
| Q3 2018 | 0 | 0 |
|---|---|---|
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 758,000 | 785,000 |
| Q4 2019 | 3,000 | 950,000 |
| Q1 2020 | 1,000 | 0 |
| Q2 2020 | 268,000 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 2,444,000 | 402,000 |
| Q1 2021 | 12,187,000 | 14,911,000 |
| Q2 2021 | 12,076,000 | 1,022,000 |
| Q3 2021 | 3,096,000 | 1,152,000 |
| Q4 2021 | 614,000 | 617,000 |
| Q1 2022 | 4,783,000 | 556,000 |
| Q2 2022 | 34,000 | 1,000 |
| Q3 2022 | 20,000 | 0 |